Fathala A, Abouzied M, AlSugair AA. Cardiac and pericardial tumors: A potential application of positron emission tomography-magnetic resonance imaging. World J Cardiol 2017; 9(7): 600-608 [PMID: 28824790 DOI: 10.4330/wjc.v9.i7.600]
Corresponding Author of This Article
Ahmed Fathala, MD, Consultant Nuclear Medicine and Cardiovascular Imaging, Department of Radiology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, MBC 28, Riyadh 11211, Saudi Arabia. afathala@kfshrc.edu.sa
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jul 26, 2017; 9(7): 600-608 Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.600
Cardiac and pericardial tumors: A potential application of positron emission tomography-magnetic resonance imaging
Ahmed Fathala, Mohei Abouzied, Abdul-Aziz AlSugair
Ahmed Fathala, Mohei Abouzied, Abdul-Aziz AlSugair, Department of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia
Author contributions: All authors contributed equally to this work.
Conflict-of-interest statement: We declare we do not have any conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Ahmed Fathala, MD, Consultant Nuclear Medicine and Cardiovascular Imaging, Department of Radiology, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, MBC 28, Riyadh 11211, Saudi Arabia. afathala@kfshrc.edu.sa
Telephone: +966-55-2532402 Fax: +966-11-4424841
Received: December 29, 2016 Peer-review started: December 31, 2016 First decision: March 28, 2017 Revised: April 20, 2017 Accepted: May 12, 2017 Article in press: May 15, 2017 Published online: July 26, 2017 Processing time: 208 Days and 22.7 Hours
Core Tip
Core tip: With the commercial availability of positron emission tomography- magnetic resonance imaging (PET-MRI) true simultaneous PET and MRI in a single study is real. Several studies have demonstrated the feasibility and incremental value of combined PET and MRI in many clinical applications. A combination of PET and MRI can provide incremental information in many cardiovascular scenarios. Evaluation of cardiac tumors may be most straightforward application for PET-MRI because it offers a unique opportunity to evaluate the tumor morphology, characterization, infiltration to adjacent structures, local and M staging and comprehensive cardiac evaluation in a single study. The purpose of this review is to provide several clinical scenarios on the incremental value of PET and MRI in the evaluation of cardiac masses.
